| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/30/2008 | US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/30/2008 | US7429485 Method of producing infectious reovirus |
| 09/30/2008 | US7429474 2-O sulfatase compositions and methods of analyzing therewith |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429452 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | CA2454871C Removable stent and method of using the same |
| 09/30/2008 | CA2450772C Composition for epigallocatechin gallate |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2309766C Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/30/2008 | CA2261989C Recombinant pox virus for immunization against tumor-associated antigens |
| 09/30/2008 | CA2261987C Vectors for inhibiting hiv and tumor growth |
| 09/30/2008 | CA2214219C Pyrido[2,3-d]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 09/30/2008 | CA2195856C Substituted o6-benzylguanines and use thereof |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/25/2008 | WO2008116161A2 Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| 09/25/2008 | WO2008116157A2 Mesenchymal stem cells and uses therefor |
| 09/25/2008 | WO2008116135A2 Topical formulations having enhanced bioavailability |
| 09/25/2008 | WO2008116129A2 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | WO2008116064A2 Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| 09/25/2008 | WO2008115920A2 Methods for the preparation and formulation of l-carnitine valproate salts |
| 09/25/2008 | WO2008115805A2 Cobalamin taxane bioconjugates |
| 09/25/2008 | WO2008115369A2 Inhibitors of focal adhesion kinase |
| 09/25/2008 | WO2008115281A2 Compounds for treating viral infections |
| 09/25/2008 | WO2008115263A2 Raf kinase inhibitors containing a zinc binding moiety |
| 09/25/2008 | WO2008115262A2 Hsp90 inhibitors containing a zinc binding moiety |
| 09/25/2008 | WO2008115259A2 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| 09/25/2008 | WO2008115140A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | WO2008115088A1 Use of rhodamine 6g in the form of a medicinal agent for treating malignant neoplasms and amiloidoses |
| 09/25/2008 | WO2008114876A1 A method of treating malignant mesothelioma |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114807A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
| 09/25/2008 | WO2008114516A1 Liposome and immunostimulating composition comprising the same |
| 09/25/2008 | WO2008114505A1 Eg5 inhibitor and agent for treatment of cell proliferative disease containing the same |
| 09/25/2008 | WO2008114501A1 Diagnostic agent and therapeutic agent for cancer |
| 09/25/2008 | WO2008114275A2 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008113856A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 09/25/2008 | WO2008113756A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/25/2008 | WO2008113711A1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/25/2008 | WO2008113686A2 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 09/25/2008 | WO2008113469A2 Substituted imidazopyrimidines and triazolopyrimidines |
| 09/25/2008 | WO2008113456A1 Tetrahydroquinoline derivatives and use of same for treating cancer |
| 09/25/2008 | WO2008113452A1 Substituted tetrahydropyrroloquinolines |
| 09/25/2008 | WO2008113451A1 Substituted tetrahydroquinolines |
| 09/25/2008 | WO2008113320A1 Lejimalid analoga and uses thereof |
| 09/25/2008 | WO2008094574A3 Furanone compounds and methods of making and using the same |
| 09/25/2008 | WO2008094556A3 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| 09/25/2008 | WO2008092103A3 Combination cancer treatments comprising elsamitrucin and other agents |
| 09/25/2008 | WO2008086128A3 Aminopyrazole kinase inhibitors |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008062466A3 Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
| 09/25/2008 | WO2008047082A3 Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 09/25/2008 | WO2008027585A3 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 09/25/2008 | WO2008021038B1 Pyridobenzazepine compounds and methods for inhibiting mitotic progression |
| 09/25/2008 | WO2008011007A3 Selective antagonists of a2a adenosine receptors |
| 09/25/2008 | WO2007077531A8 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 09/25/2008 | WO2007065027A3 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 09/25/2008 | WO2007042272A3 Use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234388 1,5-Dithiaocta-2,7-diene-5-oxide-1-yl (DODOyl) compounds and derivatives; treating, preventing, or inhibiting transmission of a viral infection |
| 09/25/2008 | US20080234378 Methods for the preparation and formulation of l-carnitine valproate salts |
| 09/25/2008 | US20080234369 3,4,5,4' - tetramethoxyl- alpha,beta-diphenylethane -3' -0- sodiumsulphate and its use |
| 09/25/2008 | US20080234368 Therapeutic compositions and methods of use |
| 09/25/2008 | US20080234363 Antitumoral Compounds |
| 09/25/2008 | US20080234361 Mixture of conjugated fatty acid(punicic acid) and polyphenol(ellagic acid); obesity, diabetes, cancer and heart disease |
| 09/25/2008 | US20080234359 Reducing tumor necrosis factor, phosphodiesterase inhibitor; anticancer agents; leukemia; antidepressants; antiinflammatory agents; respiratory system disorders |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234357 Central nervous system disorders; oxidation resistance; antitumor agents; Alzheimer's disease; 3-(2-hydroxyethyl)indole |
| 09/25/2008 | US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 09/25/2008 | US20080234348 3-Oxoindazolesquaric Acid Derivatives |
| 09/25/2008 | US20080234340 Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrile |
| 09/25/2008 | US20080234332 N,N'-diphenylureas substituted with groups including a hydroxamic acid or amide group, e.g., 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(1-(hydroxyamino)-1-oxopropan-2-yl)picolinamide; inhibiting raf kinase and histone deacetylases; antiproliferative agents |
| 09/25/2008 | US20080234324 Piperidine Derivatives as Gcs Inhibitors |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234314 2-(6-bromobenzo[d][1,3]dioxol-5-ylthio)-1-(pent-4-ynyl)-1H-imidazo [4,5-c]pyridin-4-amine; cancer, an autoimmune disease, or a neurodegenerative disease; ubiquitous chaperone protein inhibitors |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234300 Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof |
| 09/25/2008 | US20080234299 Quinazolinones |
| 09/25/2008 | US20080234298 Administering antifolate anticancer agent and methoxyamine to enhance or increase the effect of the antifolate anticancer agent |
| 09/25/2008 | US20080234297 HSP90 Inhibitors Containing a Zinc Binding Moiety |
| 09/25/2008 | US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof |
| 09/25/2008 | US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
| 09/25/2008 | US20080234285 Renin inhibitor such as (S),4(S),5(S),7(S) N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide and PDGF receptor tyrosine kinase inhibitor such as Imatinib, thrombosis, psoriasis, fibrosis, dermatosclerosis, atherosclerosis |
| 09/25/2008 | US20080234284 Pyrazolo[1,5-a]Pyrimidin-7-Yl Amine Derivatives as Protein Kinase Inhibitors |
| 09/25/2008 | US20080234283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 09/25/2008 | US20080234279 Ecteinascidins |
| 09/25/2008 | US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors |